RE:RE:Just back from rounding....SPCEO1 wrote: One issue in my mind is if the patient is non-compliant and thus ends up MDR, will they also be non-compliant with Ibalizumab? My guess is yes but you are liely in a better spot to judge. What do you think?
Certainly some will.
Others will become scared enough that they become compliant....at least for a period of time.
Regardless, they will all be new potential Ibalizumab patients and will likely be prescribed the drug at some point in their lives.
I imagine TH will have recurring revenues from a segment of the MDR HIV population while others will be on/off the drug due to compliance issues.
bfw